SEC Form 4 · accession 0001225208-15-005864
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Feb 25, 2015
Accepted (ET)
Feb 26, 2015 · 11:51 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | M | 3,617 | $47.34 | A | 30,928 | D | |
| Common StockF1 | Feb 25, 2015 | S | 3,617 | $54.824 | D | 27,311 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $47.34 | Feb 25, 2015 | M | 3,617 | D | Feb 24, 2015 | Feb 24, 2024 | Common Stock | 3,617 | 10,848 | D |
Explanation of responses
- F1This was multiple transactions on the same date with prices in the range of $54.79 to $54.875. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.